22 stories found
Maharashtra’s food safety chief has stopped dining at restaurants over widespread hygiene violations, a stance strongly endorsed by the national FSSAI head. The move underscores a renewed government push to enforce stricter food safety regulations across the state.
State FDA chief Tukaram Mundhe has initiated a massive inspection drive conducting over 3,000 raids across eateries, uncovering severe sanitation violations including pest infestations and unsafe cooking oils.
Filmmaker Kunal Kohli has publicly called upon FDA chief Tukaram Mundhe to conduct raids on Indian kitchens, expressing concerns about the prevalence of expired food items. His statement highlights issues of food safety and public health.
Maharashtra FDA chief Tukaram Mundhe has indicated his consideration of entering electoral politics, discussing his potential move with media outlets.
The Maharashtra FDA Chief reacted strongly, calling the situation 'really disgusting,' regarding food licence cancellations following a viral video depicting unhygienic soya chaap preparation.
Dr. Marty Makary's resignation from his position at the Food and Drug Administration is reportedly widening an existing leadership gap within the U.S. Department of Health and Human Services. This departure adds to ongoing concerns about leadership stability.
The Trump administration has appealed a US court decision that deemed its 10% tariff measures illegal, adding to economic uncertainty. This comes amidst other developments including a planned firing of the FDA head and monitoring of Hantavirus cases.
The U.S. Food and Drug Administration has reversed its earlier decision and will now review Moderna's application for its modified influenza vaccine.
Dr. Hisham Aljadhey, CEO of the SFDA, unveiled the ProVerifier digital tool in Riyadh to authenticate regulated products and enhance supply chain security.
State FDA officials are leading an aggressive inspection campaign against eateries, suspending permits and cracking down on unsanitary practices like the use of unregulated cooking oil.
The Maharashtra FDA chief has issued a warning to actors Shah Rukh Khan and Ajay Devgn regarding a notice concerning their endorsement of the Vimal brand, stating that action will be taken.
Saoji cuisine, a culinary legacy from Nagpur, is back in focus following a remark made by the FDA chief, prompting renewed interest in its unique flavors.
President Trump stated that the US is having 'very serious negotiations' with Iran and sees a 'good chance' for progress on a deal, warning that strikes could resume if talks fail. He also mentioned that the US has sold over $13 billion of Venezuelan oil.
A former private prison official has been appointed as the new acting director for U.S. Immigration and Customs Enforcement (ICE). This appointment has drawn attention due to his previous experience in the private prison sector.
FDA chief Marty Makary addresses the contentious period for the agency, marked by significant staff and budget cuts, and discusses changes to vaccine policy and the use of compounded GLP-1s.
Regulatory officials emphasize that advertising standards apply equally to promoters and brands, while enforcement actions continue against manufacturers and sellers violating guidelines.
FDA chief Tukaram Mundhe has stated that he has not yet received a reply from Bollywood actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff regarding their endorsement of Vimal.
The Maharashtra FDA chief has issued a stern warning, stating that 'no one will be spared' after notices were sent to prominent figures including Shah Rukh Khan, Ajay Devgn, and Tiger Shroff.
The Maharashtra FDA Chief detailed methods of milk adulteration, including the use of products like shampoo, raising concerns about food safety.
Tukaram Mundhe, the new chief of the Food and Drug Administration (FDA), stated that honest businesses have nothing to fear under his leadership.
Donald Trump is preparing for a significant summit with Chinese President Xi Jinping, where trade, Taiwan, and rare metals are expected to be key topics. This comes as his administration faces scrutiny over its stance on Iran and potential troop withdrawals from Germany.
The FDA chief warns that the U.S. is falling behind China in early drug development and calls for faster trial approvals to address bottlenecks in hospital contracting, ethical reviews, and Investigational New Drug applications.